Lilly awaits U.K. decision this week on Prozac for children

Eli Lilly will be watching closely this week while British regulators decide whether to make the company's Prozac the first anti-depressant drug approved in the U.K. for children, as it is in the U.S. The U.K. regulators have had their eye on fluoxetine, the generic name of Prozac, for nearly a year as one drug for youths that would not lead them to consider suicide and one in which the benefits outweigh the risks.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA